Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T38919 |
Protein E7(43-62)
Protein E7(43-62) |
||
Protein E7(43-62) is a peptide derived from the E7 protein. The peptide spans the 43rd to 62nd amino acid residues and exhibits anti-tumor effects. | |||
TP1595 |
Human Papillomavirus (HPV) E7 protein (49-57)
Human Papillomavirus (HPV) E7 protein 49-57 |
||
Human Papillomavirus (HPV) E7 protein (49-57) is the H-2d-restricted human papillomavirus (HPV) E749-57 epitope. | |||
T8350 |
TPCK
|
Proteasome | Proteases/Proteasome; Ubiquitination |
TPCK 是丝氨酸蛋白酶抑制剂,通过与 HPV-18 E7 蛋白的视网膜母细胞瘤蛋白 (RB) 结合核心发生反应,并能够消除其 RB 结合能力。将它添加到培养基内,可修饰活角质形成细胞中的 E7 蛋白。 | |||
T81369 |
Protein E7(43-62) TFA
|
||
Protein E7(43-62) TFA,一种E7衍生肽,覆盖E7蛋白的第43至62个氨基酸残基,具备抗肿瘤活性。 | |||
TP1515 |
HPV16-E711-20 epitope
|
||
HPV16-E711-20 epitope is a well-known HLA-A*0201-restricted human cytotoxic T lymphocyte (CTL) epitope of the HPV16 E7 protein that shows high-affinity binding to HLA-A2 in vitro. | |||
T76960 | Verpasep caltespen | ||
Verpasep caltespen (HspE7) 是一种重组融合蛋白,来源于Mycobacterium bovis Calmette-Guérin 热休克蛋白 65 (Hsp65),其 C 末端与HPV16 的 E7 蛋白共价连接。Verpasep caltespen 可用于人乳头瘤病毒 (HPV)引起的癌前病变和癌性病变研究。 |